Mccloskey Counseling Center Psychologist Medicare: Not Enrolled in Medicare Practice Location: 205 Mill St, Milesburg, PA 16853 Phone: 814-357-2400 Fax: 814-357-7740 |
News Archive
Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.
There's a low-tech problem troubling the high-tech world of digital pathology imaging.
The federal government has awarded investigators at The Johns Hopkins University's schools of medicine and public health a multimillion-dollar, five-year grant to continue research designed to identify the causes of frailty in older adults, and speed the development of interventions to slow or stop it.
Today is a meaningful milestone for chronic myelogenous leukemia (CML) patients and their families.
› Verified 6 days ago